Evidence map›Paper›PMID 31612072›Full record

Trial reportDisease markers2019

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology.

Paulina Gąsiorek, Agata Sakowicz, Maciej Banach, Stephan von Haehling, Agata Bielecka-Dabrowa

Registry-linked trialOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03377465 (Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03377465 nacompletednot on this map

Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

TypeinterventionalSponsorMedical University of LodzRan2016 to 2017Enrolled100ConditionsEmbolic Stroke of Undetermined Source, Ischemic Stroke, Atrial Fibrillation and Flutter, Myocardial InfarctionArmsADMA (asymmetric dimethylarginine) , NTproBNP (N-terminal pro b-type natriuretic peptide), IL-6 (Interleukin 6), Adiponectina, Leptine, Syndecan, Resistin
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Paulina GąsiorekDepartment of Neurology and Ischemic Strokes, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland.ORCID https://orcid.org/0000-0002-7317-279X
Agata SakowiczDepartment of Medical Biotechnology, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0002-5083-2046
Maciej BanachDepartment of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.ORCID https://orcid.org/0000-0001-6690-6874
Stephan von HaehlingDepartment of Cardiology and Pneumology, University of Göttingen Medical Center, Göttingen, Germany.
Agata Bielecka-DabrowaDepartment of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.
Medical University of Lodz · PLGerman Centre for Cardiovascular Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe study is aimed at identifying echocardiographic and circulating biomarkers as well as hemodynamic indices of embolic stroke of undetermined etiology (ESUS) in patients aged <65.

methodsWe prospectively investigated 520 patients with confirmed ischemic stroke and selected those 65 patients who were diagnosed with ESUS (age 54 (47-58) years, 42% male). An additional 36 without stroke but with a similar risk profile were included as a control group (age 53 (47-58) years, 61% male). All patients underwent echocardiography, noninvasive assessment of hemodynamic parameters using a SphygmoCor tonometer (AtCor Med., Australia), and measurements of selected biomarkers.

resultsESUS patients and controls were well matched for baseline characteristics including blood pressure and left ventricular ejection fraction (LVEF). Compared to controls, patients with ESUS had lower mean early diastolic (

conclusionsIncreased arterial stiffness and indices of diastolic dysfunction as well as a higher NT-proBNP level are significantly associated with ESUS. These parameters require further scrutiny over time to understand their impact on the development of symptomatic heart failure. The ClinicalTrials.gov identifier is NCT03377465.

Indexed as

Vascular StiffnessArginineBiomarkersCase-Control StudiesDiastoleEchocardiographyFemaleHumansInterleukin-6Intracranial EmbolismMaleMiddle AgedMitral ValveMultivariate AnalysisNatriuretic Peptide, BrainPeptide FragmentsArginineBiomarkersIL6 protein, humanInterleukin-6Natriuretic Peptide, BrainN,N-dimethylargininePeptide Fragmentspro-brain natriuretic peptide (1-76)

Identifiers

PMID31612072
PMCPMC6757252
OpenAlexW2973130460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.